Loading…
Loading…
Myelodysplastic syndromes are clonal marrow disorders causing low blood counts and a variable risk of progression to leukemia.
Quick Answer
Myelodysplastic syndromes are clonal marrow disorders causing low blood counts and a variable risk of progression to leukemia. Dr. Sachita Baniya (NMC 20158, 8+ years of clinical experience in haematology and haemato-oncology) evaluates myelodysplastic syndromes (mds) at Kathmandu Neurology Clinic & Cognitive Center, 117 Lal Durbar Marg, Kathmandu, Bagmati Province 44600, Nepal — evidence-based, medically reviewed.
MDS develops when marrow stem cells become abnormal and produce ineffective blood cells. Patients may have anaemia, infection or bleeding. Diagnosis integrates blood counts, marrow morphology, cytogenetics and molecular testing, and treatment is risk-adapted.
Diagnosis requires persistent cytopenias with dysplastic marrow features. Bone marrow aspiration and biopsy, iron staining, flow cytometry, cytogenetics and molecular testing are used, and IPSS-R estimates risk.
Lower-risk disease may be managed with observation, growth factors, transfusion support and lenalidomide in selected del(5q) cases. Higher-risk disease may receive hypomethylating agents and be considered for allogeneic transplant.
Management is individualized and discussed with benefits, limitations, and follow-up.
There is no proven prevention. Avoiding unnecessary chemotherapy and radiation, and not smoking, are reasonable general measures.
Red flags — seek urgent care
No. Some patients remain stable for years, while others progress. Risk depends on marrow blasts, cytogenetics, molecular findings and blood counts.
The Revised International Prognostic Scoring System estimates survival and progression risk using blasts, cytogenetics and cytopenias. It guides treatment intensity.
Allogeneic transplant is the only potentially curative option, but it is not suitable for every patient. Other treatments aim to control disease and improve blood counts.
Transfusions treat symptomatic anaemia or low platelets. Repeated transfusions can cause iron overload, which is monitored and sometimes treated with chelation.
These drugs can improve blood counts and slow disease progression in higher-risk MDS. They are given in cycles and require monitoring for infection and cytopenias.
Lenalidomide is particularly useful in MDS with del(5q) and can reduce transfusion needs. It requires monitoring for cytopenias and thrombosis.
Most MDS is not inherited, but some young patients have inherited marrow failure syndromes. Family history and genetic testing may be considered.
Regular blood counts, marrow assessment when indicated, transfusion review and monitoring for progression or treatment toxicity.
Risk-adapted care for myelodysplastic syndromes and unexplained cytopenias.
Donor stem cell transplant for selected high-risk blood cancers and marrow failure.
Diagnostic bone marrow sampling for cytopenias, suspected blood cancer and treatment monitoring.
Acute myeloid leukemia is a cancer of immature myeloid cells that builds up in the bone marrow and stops normal blood production.
Myeloproliferative neoplasms are clonal marrow disorders with overproduction of blood cells and a risk of thrombosis and progression.
Aplastic anaemia is a bone marrow failure disorder causing low red cells, white cells and platelets.
Haematology
AML Diagnosis Explained: From Blood Count to Genetic Risk
How acute myeloid leukemia is diagnosed, why bone marrow and genetic testing matter, and what the results mean for treatment.
Haematology
Anaemia: Why the Cause Matters More Than the Number
Anaemia is a sign, not a diagnosis. Learn how the cause is investigated and why iron tablets alone can be insufficient.
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-11-10
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.
Doctor — medically reviewed
Dr. Sachita Baniya
Consultant Haemato-Oncologist & Clinical Hematologist • MBBS, FCPS (Clinical Haematology) • NMC 20158
This condition guide was medically reviewed by Dr. Sachita Baniya.
On this site
Article information
Emergency
For sudden neurologic change, thunderclap headache, or seizure >5 min, seek emergency services now.